Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:focusesOn |
therapeutics
metabolic diseases |
| gptkbp:foundedIn |
2012
|
| gptkbp:headquartersLocation |
gptkb:Berlin,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eternygen
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableFor |
targeting sodium-coupled citrate transporter (NaCT/SLC13A5)
|
| gptkbp:website |
https://eternygen.com/
|
| gptkbp:bfsParent |
gptkb:Cord_Dohrmann
|
| gptkbp:bfsLayer |
8
|